ESTIV Awards at WC12
ESTIV Celebrates exceptional researchers presenting their science at the 12th World Congress on Alternatives and Animal Use in the Life Sciences in Canada.
ESTIV 2022 Virtual Special Issue (VSI) was published by the journal Toxicology in Vitro
ESTIV 2022 Virtual Special Issue (VSI) was published by the journal Toxicology in Vitro
ESTIV 2024 Congress Abstract submission is open!
The abstract submission is now open for the next edition of the ESTIV Congress, which will be held in Prague from June 3-6, 2024! The Abstract submission has been extended by October 31, 2023
Methods allowing the identification of an endocrine disruptors are under the focus of Pepper
Pepper, the Public-private platform for the validation of endocrine disruptors characterization methods, is looking for methods to be validated. PEPPER focuses on test methods that characterise endocrine disrupters substances
Be aware of scammers…..
Please be aware, that ESTIV and many other EU-based societies are currently facing the incased activity of scams and fraudulent e-mails requesting bank transfers to various accounts. ….
ESTIV course trained early career scientists in toxicology
The 8th ESTIV Applied Training Course took place from 29 May to 2 June at the Institute of Experimental Pharmacology and Toxicology, Centre for Experimental Medicine (CEM SAV). The course focused on innovative approaches to toxicity assessment using in vitro and in silico procedures. Sixteen young scientists from eight European countries and Turkey participated in the course.
Two ESTIV travel grants for participation in the JRC Summer School on “Non-Animal Approaches in Science: Challenges and Future Directions Copy
Two ESTIV travel grants for participation in the JRC Summer School on “Non-Animal Approaches in Science: Challenges and Future Directions
The Latest in Liver Toxicity Assessment In Vitro
We’re excited to announce that registration is now open for the upcoming joint ASCCT-ESTIV webinar titled “The Latest in Liver Toxicity Assessment In Vitro,” which will feature presentations by Magnus Ingelman-Sundberg, PhD, BSc.Med from the Karolinska Institutet, and Mathieu Vinken, PhD, PharmD, ERT from Vrije Universiteit Brussel.
ASCCT-ESTIV APRIL WEBINAR: Modeling of Adverse Outcomes – Insights from the ONTOX Project
Join us on Friday, Arpil 28 to learn about the Development of an adverse outcome pathway for kidney tubular necrosis and Computational modelling of neural tube closure defects!
Renewal of the ESTIV Board: Call for Applications
As is customary with any society, the terms of several board members are set to conclude after a certain time. We are now seeking new enthusiastic members who can join our team and help build upon the great work of our colleagues
👨🔬👩🔬 If you are passionate about promoting in vitro and in silico toxicology and contributing to the advancement of the field, we encourage you to apply!